Taysha Gene Therapies, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q4 2019 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q4 2019 to Q1 2024.
- Taysha Gene Therapies, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $1.33M, a 18.1% increase year-over-year.
- Taysha Gene Therapies, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $4.95M, a 78.5% increase from 2022.
- Taysha Gene Therapies, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.78M, a 333% increase from 2021.
- Taysha Gene Therapies, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $641K, a 2189% increase from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)